Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

meeting   publishing date : 2021 - 05 - 19    save search

ADC Therapeutics Announces Presentations at the 2021 ASCO Annual Meeting
Published: 2021-05-19 (Crawled : 00:00) - biospace.com/
ADCT | $4.72 -0.84% 0.0% 320K twitter stocktwits trandingview |
Health Technology
| | O: -2.09% H: 2.14% C: -1.07%
GMAB | $28.72 1.38% 1.36% 360K twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 0.89% C: 0.77%

presentation therapeutics
NextCure to Present Trials in Progress Poster for NC410 at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
Published: 2021-05-19 (Crawled : 23:00) - globenewswire.com
NXTC | $1.67 6.37% 5.99% 62K twitter stocktwits trandingview |
Health Technology
| | O: 1.48% H: 2.06% C: 0.73%

trial
Harpoon Therapeutics to Present Updated Interim Clinical Data for TriTAC® HPN424 at the 2021 ASCO Annual Meeting
Published: 2021-05-19 (Crawled : 22:00) - globenewswire.com
HARP | $23.01 0.07% 6.6M twitter stocktwits trandingview |
Health Technology
| | O: -0.53% H: 1.51% C: -1.12%


Iovance Biotherapeutics Announces Clinical Data Updates for Lifileucel in Advanced Melanoma at Upcoming ASCO 2021 Annual Meeting
Published: 2021-05-19 (Crawled : 22:00) - globenewswire.com
IOVA | News M | $11.32 -3.41% -3.53% 5.3M twitter stocktwits trandingview |
Health Technology
| | O: 5.63% H: 15.07% C: 8.7%

iot
MacroGenics Announces Preliminary Clinical Results from Phase 1 Study of MGC018 to be Presented at ASCO Annual Meeting
Published: 2021-05-19 (Crawled : 22:00) - globenewswire.com
MGNX | $15.62 -2.8% -2.88% 1M twitter stocktwits trandingview |
Health Technology
| | O: -0.8% H: 3.73% C: -2.9%

phase 1 results phase 3 phase 2
BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting
Published: 2021-05-19 (Crawled : 22:00) - globenewswire.com
BCTX | $2.19 -5.6% -5.94% 140K twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: -0.34% H: 7.77% C: 5.41%

results therapeutics
Sanofi to showcase data from its transformative oncology pipeline at 2021 ASCO Meeting
Published: 2021-05-19 (Crawled : 22:00) - globenewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M twitter stocktwits trandingview |
Health Technology
| | O: 1.32% H: 1.12% C: 0.92%


American Society of Clinical Oncology (ASCO) Virtual Annual Meeting 2021 – STRO-002 – Abstract
Published: 2021-05-19 (Crawled : 21:00) - sutrobio.com
STRO | $3.635 -3.58% -3.71% 520K twitter stocktwits trandingview |
Health Technology
| | O: 1.58% H: 2.43% C: -10.66%


PolyPid Announces Positive FDA Type B Meeting Feedback for D-PLEX₁₀₀ Development Program
Published: 2021-05-19 (Crawled : 21:00) - biospace.com/
PYPD | $4.5 4.65% 4.44% 1.3K twitter stocktwits trandingview |
Health Technology
| | O: 3.26% H: 1.05% C: 0.42%

fda positive
Kronos Worldwide, Inc. Announces Quarterly Dividend and Results of Annual Stockholder Meeting
Published: 2021-05-19 (Crawled : 21:00) - globenewswire.com
KRO | $11.33 0.35% 0.0% 170K twitter stocktwits trandingview |
Process Industries
| | O: 0.42% H: 1.88% C: -1.02%

results
NexImmune Announces Presentation of Preliminary Phase 1/2 Clinical Data at the 2021 American Society of Clinical Oncology Annual Meeting
Published: 2021-05-19 (Crawled : 21:00) - globenewswire.com
NEXI | $3.22 -2.42% -2.48% 23K twitter stocktwits trandingview |
| | O: -1.44% H: 4.93% C: 2.66%

presentation phase 1 phase 3 phase 2
DBV Technologies Announces Results of its 2021 Ordinary and Extraordinary General Meeting and the Appointment of Dr. Adora Ndu, Pharm.D., J.D., and Dr. Ravi Madduri Rao, M.D., Ph.D., as Members of its Board of Directors
Published: 2021-05-19 (Crawled : 21:00) - globenewswire.com
DBVT | $0.671 1.51% 1.49% 39K twitter stocktwits trandingview |
Health Technology
| | O: 0.17% H: 3.14% C: 2.31%

results
Profound Medical Announces Voting Results from the 2021 Annual Meeting of Shareholders and Management Changes
Published: 2021-05-19 (Crawled : 21:00) - globenewswire.com
PROF | $7.85 -5.42% -5.73% 17K twitter stocktwits trandingview |
Health Technology
| | O: 0.33% H: 3.83% C: 2.39%

results
Medical Affairs: Meeting the Challenges of COVID-19 and Omnichannel Engagement
Published: 2021-05-19 (Crawled : 18:00) - veeva.com
VEEV | $198.38 -0.58% 0.0% 730K twitter stocktwits trandingview |
Technology Services
| | O: -1.52% H: 2.53% C: 1.89%

covid covid-19
BJ’s Restaurants, Inc. Announces Virtual Format for 2021 Annual Meeting of Shareholders
Published: 2021-05-19 (Crawled : 18:00) - globenewswire.com
BJRI | $32.135 0.86% 0.86% 290K twitter stocktwits trandingview |
Consumer Services
| | O: -1.25% H: 0.52% C: -0.51%

restaurant
Copperstone Resources AB: Communiqué from Annual General Meeting
Published: 2021-05-19 (Crawled : 17:00) - globenewswire.com
ERIC | News | $5.1 0.79% 0.78% 19M twitter stocktwits trandingview |
Electronic Technology
| | O: -0.67% H: 0.98% C: 0.83%


CORBUS PHARMACEUTICALS ANNOUNCES ADJOURNMENT OF ANNUAL MEETING
Published: 2021-05-19 (Crawled : 14:00) - globenewswire.com
CRBP | $39.12 7.09% 6.62% 280K twitter stocktwits trandingview |
Health Technology
| | O: -4.29% H: 4.49% C: 3.85%


Metacrine to Present New Preclinical Data on MET642 in Inflammatory Bowel Disease at Digestive Disease Week 2021 Virtual Meeting
Published: 2021-05-19 (Crawled : 12:15) - globenewswire.com
MTCR | $0.5814 -5.14% 84K twitter stocktwits trandingview |
Health Technology
| | O: -3.01% H: 2.82% C: -0.85%

disease met642 preclinical pre-clinical
Reata Announces that The FDA Has Asked The Company to Request a Pre-NDA Meeting for Omaveloxolone for the Treatment of Friedreich’s Ataxia
Published: 2021-05-19 (Crawled : 11:00) - globenewswire.com
RETA | $172.36 0.02% 0.03% 0 twitter stocktwits trandingview |
Health Technology
| | O: 13.45% H: 9.49% C: 9.11%

treatment fda friedreich's ataxia friedreich’s ataxia
Gainers vs Losers
67% 33%

Top 10 Gainers

Your saved searches
Save your searches and get alerts when important news are released.